Europe Histopathology Services Market by Type of Examination (Surgical Specimen, Gastrointestinal Biopsy, Breast Biopsy, Lung Biopsy, Biopsy of Gynecological Cancers, Renal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Liver Biopsy, Nerve Biopsy, and Testicular Biopsy) - Opportunity Analysis and Industry Forecast, 2017-2023
The Europe histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.
Histopathology is a branch of pathology, which deals with the microscopic analysis of biological tissues to detect the presence of diseased cells/tissues. It involves the study of infinitesimal changes/aberrations in tissues that are caused due to some diseases. Histopathology tests are conducted in histopathology laboratories, wherein a pathologist studies changes or abnormalities in tissues caused by a disease.
The growth of the Europe histopathology services market is driven by increase in prevalence of cancer & other chronic disorders, rapid surge in geriatric population in Europe, and rise in public awareness for disease screening. However, limitations of histopathology and dearth in number pathologists & medical laboratory scientists in the UK restrain the growth of the market. Conversely, increase in demand for personalized medicine is expected to provide potential opportunities for market expansion during the forecast period.
The report segments the Europe histopathology services market based on type of examination and country. Depending on type of examination, the market is fragmented into surgical specimen, gastrointestinal biopsy, breast biopsy, lung biopsy, biopsy of gynecological cancers, renal biopsy, pancreatic biopsy, skin tissue biopsy, liver biopsy, nerve biopsy, testicular biopsy, and others. On the basis of country, it is analyzed across Germany, France, the UK, Spain, and rest of Europe.
KEY BENEFITS FOR STAKEHOLDERS
By Type of Examination
Histopathology is a branch of pathology, which deals with the microscopic analysis of biological tissues to detect the presence of diseased cells/tissues. It involves the study of infinitesimal changes/aberrations in tissues that are caused due to some diseases. Histopathology tests are conducted in histopathology laboratories, wherein a pathologist studies changes or abnormalities in tissues caused by a disease.
The growth of the Europe histopathology services market is driven by increase in prevalence of cancer & other chronic disorders, rapid surge in geriatric population in Europe, and rise in public awareness for disease screening. However, limitations of histopathology and dearth in number pathologists & medical laboratory scientists in the UK restrain the growth of the market. Conversely, increase in demand for personalized medicine is expected to provide potential opportunities for market expansion during the forecast period.
The report segments the Europe histopathology services market based on type of examination and country. Depending on type of examination, the market is fragmented into surgical specimen, gastrointestinal biopsy, breast biopsy, lung biopsy, biopsy of gynecological cancers, renal biopsy, pancreatic biopsy, skin tissue biopsy, liver biopsy, nerve biopsy, testicular biopsy, and others. On the basis of country, it is analyzed across Germany, France, the UK, Spain, and rest of Europe.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Analysis by type of examination helps to understand the various types of histopathological tests and tissues used for a histopathological examination.
- Comprehensive analysis of major countries in Europe is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By Type of Examination
- Surgical Specimen
- Gastrointestinal Biopsy
- Breast Biopsy
- Lung Biopsy
- Biopsy of Gynecological Cancers
- Renal Biopsy
- Pancreatic Biopsy
- Skin Tissue Biopsy
- Liver Biopsy
- Nerve Biopsy
- Testicular Biopsy
- Others
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Acculabs Diagnostics UK Ltd.
- Cellular Pathology Services Limited
- Great Ormond Street Hospital (GOSH) Laboratory
- HCA Laboratories UK
- Laboratoire Cerba
- Sonic Healthcare Limited
- Spire Healthcare Group Plc.
- Targos Molecular Pathology GmbH
- TPL Path Labs
- Unilabs Group Services
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in prevalence of cancer and other chronic disorders
3.3.1.2. Rapid growth in geriatric population
3.3.1.3. Rise in public awareness for disease screening
3.3.2. Restraints
3.3.2.1. Limitations of histopathology
3.3.2.2. Shortage of pathologists in the UK
3.3.3. Opportunity
3.3.3.1. Increase in demand for personalized medicine
CHAPTER 4: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical specimen
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Gastrointestinal biopsy
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Breast biopsy
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.5. Lung biopsy
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.6. Biopsy for gynecological cancers
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.7. Renal biopsy
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.8. Pancreatic biopsy
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.9. Skin tissue biopsy
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.10. Liver biopsy
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.11. Nerve biopsy
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.12. Testicular biopsy
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
CHAPTER 5: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Germany
5.2.1. Market size and forecast
5.3. France
5.3.1. Market size and forecast
5.4. UK
5.4.1. Market size and forecast
5.5. Italy
5.5.1. Market size and forecast
5.6. Spain
5.6.1. Market size and forecast
5.7. Rest of Europe
5.7.1. Market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Acculabs Diagnostics UK Ltd.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segment
6.2. Cellular Pathology Services Limited
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.3. Great Ormond Street Hospital (GOSH) Laboratory
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.4. HCA Laboratories UK
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segment
6.5. Laboratoire Cerba
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.6. Sonic Healthcare Limited
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance
6.7. Spire Healthcare Group Plc
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Business performance
6.7.4. Key strategic moves and developments
6.8. Targos Molecular Pathology GmbH
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.9. TPL Path Labs
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.10. Unilabs Group Services
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in prevalence of cancer and other chronic disorders
3.3.1.2. Rapid growth in geriatric population
3.3.1.3. Rise in public awareness for disease screening
3.3.2. Restraints
3.3.2.1. Limitations of histopathology
3.3.2.2. Shortage of pathologists in the UK
3.3.3. Opportunity
3.3.3.1. Increase in demand for personalized medicine
CHAPTER 4: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical specimen
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Gastrointestinal biopsy
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Breast biopsy
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.5. Lung biopsy
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.6. Biopsy for gynecological cancers
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.7. Renal biopsy
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.8. Pancreatic biopsy
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.9. Skin tissue biopsy
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.10. Liver biopsy
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.11. Nerve biopsy
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.12. Testicular biopsy
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
CHAPTER 5: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Germany
5.2.1. Market size and forecast
5.3. France
5.3.1. Market size and forecast
5.4. UK
5.4.1. Market size and forecast
5.5. Italy
5.5.1. Market size and forecast
5.6. Spain
5.6.1. Market size and forecast
5.7. Rest of Europe
5.7.1. Market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Acculabs Diagnostics UK Ltd.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segment
6.2. Cellular Pathology Services Limited
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.3. Great Ormond Street Hospital (GOSH) Laboratory
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.4. HCA Laboratories UK
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segment
6.5. Laboratoire Cerba
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.6. Sonic Healthcare Limited
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance
6.7. Spire Healthcare Group Plc
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Business performance
6.7.4. Key strategic moves and developments
6.8. Targos Molecular Pathology GmbH
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.9. TPL Path Labs
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.10. Unilabs Group Services
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Key strategic moves and developments
LIST OF TABLES
TABLE 01. INCIDENCE, MORTALITY, AND PREVALENCE OF ALL CANCER TYPES IN EUROPE (EXCLUDING NON-MELANOMA SKIN CANCER), 2012
TABLE 02. AVERAGE NUMBER OF NEW CANCER CASES PER YEAR AND AGE-SPECIFIC INCIDENCE RATES PER 100,000 POPULATION IN UK, 2013-2015
TABLE 03. AVERAGE NUMBER OF CELLULAR PATHOLOGY STAFF FTE IN A LABORATORY (EXCLUDING UNCATEGORIZED STAFF)
TABLE 04. EUROPE HISTOPATHOLOGY SERVICES MARKET REVENUE, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 05. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SURGICAL SPECIMEN, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 06. INCIDENCE AND MORTALITY OF GASTRIC CANCER IN EUROPE, 2012
TABLE 07. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR GASTROINTESTINAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 08. INCIDENCE AND MORTALITY OF BREAST CANCER IN EUROPE, 2012
TABLE 09. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BREAST BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. INCIDENCE AND MORTALITY OF LUNG CANCER IN EUROPE, 2012
TABLE 11. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LUNG BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 12. INCIDENCE AND MORTALITY OF OVARIAN CANCER IN EUROPE, 2012
TABLE 13. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BIOPSY FOR GYNECOLOGICAL CANCERS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. INCIDENCE AND MORTALITY OF KIDNEY CANCER IN EUROPE, 2012
TABLE 15. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR RENAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. INCIDENCE AND MORTALITY OF PANCREATIC CANCER IN EUROPE, 2012
TABLE 17. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR PANCREATIC BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. INCIDENCE AND MORTALITY OF MALIGNANT MELANOMA OF SKIN IN EUROPE, 2012
TABLE 19. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SKIN TISSUE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. INCIDENCE AND MORTALITY OF LIVER CANCER IN EUROPE, 2012
TABLE 21. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LIVER BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR NERVE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. INCIDENCE AND MORTALITY OF TESTICULAR CANCER IN EUROPE, 2012
TABLE 24. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR TESTICULAR BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR OTHER EXAMINATIONS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. GERMANY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 28. FRENCH POPULATION (% OF THE TOTAL POPULATION) BY MAJOR AGE GROUPS
TABLE 29. FRANCE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 30. UK HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 31. ITALY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 32. SPAIN HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 33. MID-YEAR POPULATION BY AGE GROUP AND SEX, EUROPE, 2017 (%)
TABLE 34. REST OF EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 35. ACCULABS DIAGNOSTICS UK LTD.: COMPANY SNAPSHOT
TABLE 36. ACCULABS DIAGNOSTICS UK LTD.: SERVICES
TABLE 37. CELLULAR PATHOLOGY SERVICES LIMITED: COMPANY SNAPSHOT
TABLE 38. CELLULAR PATHOLOGY SERVICES LIMITED: SERVICES
TABLE 39. GOSH: COMPANY SNAPSHOT
TABLE 40. GOSH: SERVICES
TABLE 41. HCA LABORATORIES: COMPANY SNAPSHOT
TABLE 42. HCA LABORATORIES: SERVICES
TABLE 43. LABORATOIRE CERBA: COMPANY SNAPSHOT
TABLE 44. LABORATOIRE CERBA: SERVICES
TABLE 45. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 46. SONIC HEALTHCARE LIMITED: OPERATING SEGMENTS
TABLE 47. SPIRE HEALTHCARE GROUP PLC: COMPANY SNAPSHOT
TABLE 48. TARGOS MOLECULAR PATHOLOGY GMBH: COMPANY SNAPSHOT
TABLE 49. TARGOS MOLECULAR PATHOLOGY GMBH: OPERATING SEGMENTS
TABLE 50. TPL PATH LABS: COMPANY SNAPSHOT
TABLE 51. TPL PATH LABS: SERVICES
TABLE 52. UNILABS GROUP SERVICES: COMPANY SNAPSHOT
TABLE 53. UNILABS GROUP SERVICES: OPERATING SEGMENTS
TABLE 01. INCIDENCE, MORTALITY, AND PREVALENCE OF ALL CANCER TYPES IN EUROPE (EXCLUDING NON-MELANOMA SKIN CANCER), 2012
TABLE 02. AVERAGE NUMBER OF NEW CANCER CASES PER YEAR AND AGE-SPECIFIC INCIDENCE RATES PER 100,000 POPULATION IN UK, 2013-2015
TABLE 03. AVERAGE NUMBER OF CELLULAR PATHOLOGY STAFF FTE IN A LABORATORY (EXCLUDING UNCATEGORIZED STAFF)
TABLE 04. EUROPE HISTOPATHOLOGY SERVICES MARKET REVENUE, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 05. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SURGICAL SPECIMEN, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 06. INCIDENCE AND MORTALITY OF GASTRIC CANCER IN EUROPE, 2012
TABLE 07. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR GASTROINTESTINAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 08. INCIDENCE AND MORTALITY OF BREAST CANCER IN EUROPE, 2012
TABLE 09. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BREAST BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 10. INCIDENCE AND MORTALITY OF LUNG CANCER IN EUROPE, 2012
TABLE 11. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LUNG BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 12. INCIDENCE AND MORTALITY OF OVARIAN CANCER IN EUROPE, 2012
TABLE 13. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR BIOPSY FOR GYNECOLOGICAL CANCERS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 14. INCIDENCE AND MORTALITY OF KIDNEY CANCER IN EUROPE, 2012
TABLE 15. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR RENAL BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. INCIDENCE AND MORTALITY OF PANCREATIC CANCER IN EUROPE, 2012
TABLE 17. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR PANCREATIC BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. INCIDENCE AND MORTALITY OF MALIGNANT MELANOMA OF SKIN IN EUROPE, 2012
TABLE 19. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR SKIN TISSUE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. INCIDENCE AND MORTALITY OF LIVER CANCER IN EUROPE, 2012
TABLE 21. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR LIVER BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR NERVE BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. INCIDENCE AND MORTALITY OF TESTICULAR CANCER IN EUROPE, 2012
TABLE 24. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR TESTICULAR BIOPSY, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. EUROPE HISTOPATHOLOGY SERVICES MARKET FOR OTHER EXAMINATIONS, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 26. EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. GERMANY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 28. FRENCH POPULATION (% OF THE TOTAL POPULATION) BY MAJOR AGE GROUPS
TABLE 29. FRANCE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 30. UK HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 31. ITALY HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 32. SPAIN HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 33. MID-YEAR POPULATION BY AGE GROUP AND SEX, EUROPE, 2017 (%)
TABLE 34. REST OF EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION, 2016-2023 ($MILLION)
TABLE 35. ACCULABS DIAGNOSTICS UK LTD.: COMPANY SNAPSHOT
TABLE 36. ACCULABS DIAGNOSTICS UK LTD.: SERVICES
TABLE 37. CELLULAR PATHOLOGY SERVICES LIMITED: COMPANY SNAPSHOT
TABLE 38. CELLULAR PATHOLOGY SERVICES LIMITED: SERVICES
TABLE 39. GOSH: COMPANY SNAPSHOT
TABLE 40. GOSH: SERVICES
TABLE 41. HCA LABORATORIES: COMPANY SNAPSHOT
TABLE 42. HCA LABORATORIES: SERVICES
TABLE 43. LABORATOIRE CERBA: COMPANY SNAPSHOT
TABLE 44. LABORATOIRE CERBA: SERVICES
TABLE 45. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 46. SONIC HEALTHCARE LIMITED: OPERATING SEGMENTS
TABLE 47. SPIRE HEALTHCARE GROUP PLC: COMPANY SNAPSHOT
TABLE 48. TARGOS MOLECULAR PATHOLOGY GMBH: COMPANY SNAPSHOT
TABLE 49. TARGOS MOLECULAR PATHOLOGY GMBH: OPERATING SEGMENTS
TABLE 50. TPL PATH LABS: COMPANY SNAPSHOT
TABLE 51. TPL PATH LABS: SERVICES
TABLE 52. UNILABS GROUP SERVICES: COMPANY SNAPSHOT
TABLE 53. UNILABS GROUP SERVICES: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 01. EUROPE HISTOPATHOLOGY SERVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN GERMANY, 2015 (%)
FIGURE 04. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN FRANCE, 2015 (%)
FIGURE 05. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN UK, 2015 (%)
FIGURE 06. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN ITALY, 2015 (%)
FIGURE 07. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN SPAIN, 2015 (%)
FIGURE 08. SONIC HEALTHCARE LIMITED: NET SALES, 2015-2017 ($MILLION)
FIGURE 09. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 10. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 11. SPIRE HEALTHCARE GROUP PLC: NET SALES, 2014-2016 ($MILLION)
FIGURE 12. SPIRE HEALTHCARE GROUP PLC: REVENUE SHARE BY CUSTOMER, 2016 (%)
FIGURE 01. EUROPE HISTOPATHOLOGY SERVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN GERMANY, 2015 (%)
FIGURE 04. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN FRANCE, 2015 (%)
FIGURE 05. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN UK, 2015 (%)
FIGURE 06. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN ITALY, 2015 (%)
FIGURE 07. MAJOR SURGICAL PROCEDURES INVOLVING HISTOPATHOLOGY IN SPAIN, 2015 (%)
FIGURE 08. SONIC HEALTHCARE LIMITED: NET SALES, 2015-2017 ($MILLION)
FIGURE 09. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 10. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 11. SPIRE HEALTHCARE GROUP PLC: NET SALES, 2014-2016 ($MILLION)
FIGURE 12. SPIRE HEALTHCARE GROUP PLC: REVENUE SHARE BY CUSTOMER, 2016 (%)
